In "No Time to Quit," Dr. Osterholm and Chris Dall discuss the JN.1 variant, Paxlovid uptake, and COVID-19 vaccine disinformation. Dr. Osterholm also provides an update on influenza and RSV transmission and shares the latest "This Week in Public Health History" segment.&nbsp;
<ul>
	<a href="https://www.latimes.com/opinion/story/2024-01-04/covid-2024-flu-virus-vaccine">Opinion: The U.S. is facing the biggest COVID wave since Omicron. Why are we still playing make-believe?</a> (Eric Topol, LA Times) 
	<a href="https://www.nytimes.com/2024/01/04/health/paxlovid-covid-treatment.html">Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It</a> (Christina Jewett,&nbsp;New York Times) 
	<a href="https://www.cidrap.umn.edu/covid-19/commentary-what-can-masks-do-part-1-science-behind-covid-19-protection">COMMENTARY: What can masks do? Part 1: The science behind COVID-19 protection</a> (Brosseau et al.,&nbsp;CIDRAP)
</ul>

Osterholm Update

Episode 148: No Time to Quit

A weekly report on the COVID-19 pandemic from infectious disease expert Michael Osterholm, PhD, MPH. Dr. Osterholm is the director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and has spent a career investigating outbreaks. Since 2005, he has emphasized supply chain and other vulnerabilities and a critical need for pandemic preparedness. In this podcast, Dr. Osterholm dissects the latest COVID-19 news, data, and guidance.
CIDRAP’s Chris Dall, MA, is the cohost of the Osterholm Update and a reporter for CIDRAP News. http://www.cidrap.umn.edu
